A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects
Kamran Hosseini,1 Thomas Walters,2 Robert DaVanzo,3 Richard L Lindstrom4 1InSite Vision Inc., Alameda, CA, 2Texan Eye, Austin, TX, 3Cornerstone Health Care, High Point, NC, 4Minnesota Eye Consultants, Bloomington, MN, USA Purpose: The aim of this study was to evaluate the safety, tolerability, and...
Guardado en:
Autores principales: | Hosseini K, Walters T, DaVanzo R, Lindstrom RL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/323bdb8658744f6181625e47c23b4107 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review
por: Sheppard JD
Publicado: (2016) -
Use of topical bromfenac for treating ocular pain and inflammation beyond cataract surgery: a review of published studies
por: Schechter BA
Publicado: (2019) -
Comparing Combination Drop Therapy to a Standard Drop Regimen After Routine Cataract Surgery
por: Solomon KD, et al.
Publicado: (2020) -
Bromfenac 0.09% bioavailability in aqueous humor, prophylactic effect on cystoid macular edema, and clinical signs of ocular inflammation after phacoemulsification in a Mexican population
por: Palacio C, et al.
Publicado: (2016) -
Fixed-Combination Eye Drops Based on Fluorometholone Nanoparticles and Bromfenac/Levofloxacin Solution Improve Drug Corneal Penetration
por: Otake H, et al.
Publicado: (2021)